Reproductive Health Devices are used to manage conditions related to the reproductive system, its functions and processes. The Reproductive Health Devices include Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices, Assisted Reproductive Technology (ART) Devices, and Postpartum Hemorrhage Control Devices. Reversible Contraceptive Devices are used as birth control to prevent unwanted pregnancy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reversible contraceptive devices devices market, including market shares of different players within Ireland. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the reversible contraceptive devices market in Ireland was Bayer followed by Organon, Shanghai Dahua Pharmaceuticals, HLL Lifecare, CooperSurgical, Allergan Aesthetics, Meril Life Sciences and Pregna International.
Reversible Contraceptive Devices are inserted or implanted into women of child-bearing age, often for long periods of time. Intrauterine Devices (IUDs), Diaphragms and Hormonal Implants are tracked under Reversible Contraceptive Devices.
The value of the reversible contraceptive devices devices market within Ireland was expected to be over $3m in 2023.
For the latest complete market share analysis of reversible contraceptive devices device market in Ireland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.